Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$5.66
-0.3%		$5.92
$4.33
▼
$8.00
$2.12B0.372.48 million shs1.91 million shs
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$28.22
+0.5%		$28.46
$23.00
▼
$29.65
N/AN/A101,532 shs52,613 shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$146.53
-0.2%		$138.45
$77.58
▼
$156.92
$361.50B0.219.81 million shs31.14 million shs
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
$22.00
$20.67
$12.71
▼
$31.05
$8.25M0.9821,861 shs12,589 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
0.00%-3.42%-11.92%+21.22%-15.97%
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
0.00%-1.69%-2.96%+5.67%+15.86%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%+1.74%-3.87%+26.89%+79.98%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
0.00%+2.42%-0.09%+8.96%+15.21%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$5.66
-0.3%		$5.92
$4.33
▼
$8.00
$2.12B0.372.48 million shs1.91 million shs
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$28.22
+0.5%		$28.46
$23.00
▼
$29.65
N/AN/A101,532 shs52,613 shs
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$146.53
-0.2%		$138.45
$77.58
▼
$156.92
$361.50B0.219.81 million shs31.14 million shs
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
$22.00
$20.67
$12.71
▼
$31.05
$8.25M0.9821,861 shs12,589 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
0.00%-3.42%-11.92%+21.22%-15.97%
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
0.00%-1.69%-2.96%+5.67%+15.86%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.00%+1.74%-3.87%+26.89%+79.98%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
0.00%+2.42%-0.09%+8.96%+15.21%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
1.86
Reduce$8.0041.47% Upside
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
0.00
N/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2.71
Moderate Buy$154.245.26% Upside
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest WEED, BHC, MRK, HIK, and EVT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/10/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
HSBC Holdings plc logo
HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$150.00 ➝ $172.00
9/9/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Leerink Partners logo
Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$127.00 ➝ $161.00
9/8/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$146.00 ➝ $170.00
9/4/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$150.00 ➝ $170.00
8/25/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/25/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Wolfe Research logo
Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$155.00 ➝ $180.00
8/25/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$145.00 ➝ $170.00
8/21/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$140.00 ➝ $160.00
8/20/2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/20/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$142.00 ➝ $170.00
8/20/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$145.00 ➝ $175.00
(Data available from 9/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$10.27B0.21$7.25 per share0.78$1.02 per share5.54
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$476.77MN/AN/AN/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$65.01B5.56$11.39 per share12.86$21.22 per share6.91
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$157M-$2.96N/A1.41N/A-10.12%-561.95%6.31%10/28/2026 (Estimated)
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$18.25B$1.25117.2215.176.394.77%16.73%6.13%10/29/2026 (Estimated)
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest WEED, BHC, MRK, HIK, and EVT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2026Q2 2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
-$0.26-$0.13+$0.13-$0.54$16.37 billion$16.61 billion
7/29/2026Q2 2026
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
$0.96$1.26+$0.30$0.68$2.59 billion$2.83 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
N/AN/AN/AN/AN/A
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
$1.976.98%N/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$3.402.32%+5.75%272.00%14 Years
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/AN/AN/A

Latest WEED, BHC, MRK, HIK, and EVT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/29/2026
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
quarterly$0.852.36%9/15/20269/15/202610/7/2026
9/1/2026
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16467.04%9/15/20269/15/20269/30/2026
8/3/2026
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16466.72%8/14/20268/14/20268/31/2026
7/1/2026
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
monthly$0.16467.26%7/15/20267/15/20267/31/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
54.68
1.44
1.08
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1.22
1.32
1.10
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
78.65%
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
76.07%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A

Insider Ownership

CompanyInsider Ownership
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
20.67%
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/A
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
0.17%
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Bausch Health Cos Inc. stock logo
BHC
Bausch Health Cos
20,300374.14 million296.81 millionOptionable
EVT
Eaton Vance Tax-Advantaged Dividend Income Fund
N/AN/AN/ANot Optionable
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
75,0002.47 billion2.46 billionOptionable
Roundhill Cannabis ETF stock logo
WEED
Roundhill Cannabis ETF
N/A375,000N/ANot Optionable

Recent News About These Companies

Cours Roundhill Cannabis ETF - USD
September 13, 2026  |  zonebourse.comZ
Roundhill Cannabis ETF (BATS:WEED) Short Interest Update
September 11, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31016264
Roundhill Cannabis ETF (BATS:WEED) Shares Down 1.8% - Time to Sell?
September 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31013835
Roundhill Cannabis ETF
August 18, 2026  |  markets.ft.comhttps://markets.ft.com/data/etfs/tearsheet/summary?s=WEED:BTQ:USD
Listed Funds Trust - Roundhill Cannabis ETF
June 24, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/weed-listed-funds-trust-roundhill-cannabis-etf
5 ETFs Up At Least 5% Last Week's Market Rout
June 10, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2935285/5-etfs-up-at-least-5-last-week-s-market-rout?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2935285
100 Days Into the Iran War: Winning & Losing ETF Areas
June 8, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2933607/100-days-into-the-iran-war-winning-losing-etf-areas?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2933607
US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?
May 14, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2921525/us-reclassifies-weed-can-cannabis-etfs-give-your-portfolio-a-new-high?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2921525
Sector ETFs rally in April despite inflation and growth concerns
May 5, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/sector-etfs-rally-in-april-despite-inflation-and-growth-concerns/gm-GMBF0D3441
Best-Performing ETFs of April
May 5, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2914473/best-performing-etfs-of-april?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2914473
Cannabis ETFs: Regulatory Momentum Returns Focus
April 30, 2026  |  etftrends.comE
ETF sectors rally on chip surge, cannabis gains, oil jump
April 29, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/etf-sectors-rally-on-chip-surge-cannabis-gains-oil-jump/gm-GM17BC3388
ETF sectors rally as healthcare CapEx growth accelerates
April 28, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/etf-sectors-rally-as-healthcare-capex-growth-accelerates/gm-GM8CDC252B
Semiconductors, cannabis ETFs lead gains as sector rotation accelerates
April 28, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/semiconductors-cannabis-etfs-lead-gains-as-sector-rotation-accelerates/gm-GM7C8E74D8
4 Best-Performing ETF Areas of Last Week
April 28, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2909237/4-best-performing-etf-areas-of-last-week?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2909237
How to buy marijuana stocks: A beginner’s guide
March 27, 2026  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/how-to-buy-marijuana-stocks-a-beginner-s-guide/ar-AA1V1gHo
Roundhill Cannabis ETF : WEED
March 24, 2026  |  247wallst.comhttps://247wallst.com/companies/weed/
Santa Rally Falls Short: Top ETF Performers of December
January 2, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2811211/santa-rally-falls-short-top-etf-performers-of-december?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2811211
Cannabis ETFs surge on Trump's reclassification review
December 18, 2025  |  msn.comhttps://www.msn.com/en-xl/news/other/cannabis-etfs-surge-on-trump-s-reclassification-review/ar-AA1SA2lM
Cannabis ETF (WEED) Hits a New 52-Week High
December 17, 2025  |  zacks.comhttps://www.zacks.com/stock/news/2805373/cannabis-etf-weed-hits-a-new-52-week-high?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2805373

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Laptop displaying a U.S. Treasury yield curve chart on a desk with monitors showing stock market data.
3 ETFs That Could Move as Rate Expectations Shift
By Dan Schmidt | September 6, 2026
Scientist handles blood sample in lab, symbolizing early cancer detection.
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
By Bridget Bennett | September 6, 2026
A candlestick stock price chart overlaid on a blurred urban skyline at dusk.
MarketBeat Week in Review – 08/31 - 09/04
By Chris Markoch | September 5, 2026
Illustration of ascending coin and cash stacks with an upward arrow line graph symbolizing financial growth.
From High Dividend Growth to High Yield, These 3 Stocks Just Boosted Dividend Payouts
By Leo Miller | September 2, 2026
Salesforce cloud logo overlaid on a city skyline with upward-trending stock chart graphics and mountain backdrop.
Salesforce Turns the Corner as AI Fears Start to Fade
By Thomas Hughes | August 28, 2026
Bausch Health Cos stock logo

Bausch Health Cos NYSE:BHC

$5.66 -0.02 (-0.26%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$5.70 +0.04 (+0.76%)
As of 09/18/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Eaton Vance Tax-Advantaged Dividend Income Fund NYSE:EVT

$28.22 +0.15 (+0.53%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$28.06 -0.16 (-0.56%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Eaton Vance Tax-Advantaged Dividend Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across the diversified sectors. The fund primarily invests in dividend paying value stocks of companies that qualify for favorable federal income tax treatment. It benchmarks the performance of its portfolio against the Russell 1000 Value Index. Eaton Vance Tax-Advantaged Dividend Income Fund was formed on September 30, 2003 and is domiciled in the United States.

Merck & Co., Inc. stock logo

Merck & Co., Inc. NYSE:MRK

$146.52 -0.35 (-0.23%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$146.57 +0.04 (+0.03%)
As of 09/18/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Roundhill Cannabis ETF stock logo

Roundhill Cannabis ETF BATS:WEED

$22.00 0.00 (0.00%)
Closing price 09/18/2026 04:10 PM Eastern
Extended Trading
$22.02 +0.02 (+0.09%)
As of 09/18/2026 06:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas